These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22102385)

  • 1. The retrospective cohort study for survival rate in patients with advanced hepatocellular carcinoma receiving radiotherapy or palliative care.
    Eun HS; Kim MJ; Kim HJ; Ko KH; Moon HS; Lee ES; Kim SH; Lee HY; Lee BS
    Korean J Hepatol; 2011 Sep; 17(3):189-98. PubMed ID: 22102385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential prognostic benefits of radiotherapy as an initial treatment for patients with unresectable advanced hepatocellular carcinoma with invasion to intrahepatic large vessels.
    Nakazawa T; Adachi S; Kitano M; Isobe Y; Kokubu S; Hidaka H; Ono K; Okuwaki Y; Watanabe M; Shibuya A; Saigenji K
    Oncology; 2007; 73(1-2):90-7. PubMed ID: 18337620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective transarterial chemoembolization of advanced hepatocellular carcinomas: a reasonable palliative option.
    Timm S; Sotiropoulos GC; Draier M; Knüpffer J; Steger U; Lang H
    Transplant Proc; 2008 Nov; 40(9):3179-81. PubMed ID: 19010226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy treatment of adrenal gland metastases from hepatocellular carcinoma: clinical features and prognostic factors.
    Zhou LY; Zeng ZC; Fan J; Chen B; Rao SX; He J; Yang P; Hou JZ; Wu ZF; Zhang JY; Hu Y
    BMC Cancer; 2014 Nov; 14():878. PubMed ID: 25421498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients.
    Zeng ZC; Tang ZY; Fan J; Qin LX; Ye SL; Zhou J; Sun HC; Wang BL; Wang JH
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1067-76. PubMed ID: 15913915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-biologically effective dose palliative radiotherapy for a tumor thrombus might improve the long-term prognosis of hepatocellular carcinoma: a retrospective study.
    Kong XQ; Dong YP; Wu JX; He JY; Le YY; Du KX; Peng QQ; Li JL
    Radiat Oncol; 2017 May; 12(1):92. PubMed ID: 28569169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy for 65 patients with advanced unresectable hepatocellular carcinoma.
    Seo YS; Kim JN; Keum B; Park S; Kwon YD; Kim YS; Jeen YT; Chun HJ; Kim CY; Kim CD; Ryu HS; Um SH
    World J Gastroenterol; 2008 Apr; 14(15):2394-400. PubMed ID: 18416468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the six-and-twelve criteria among patients with hepatocellular carcinoma and performance score 1 receiving transarterial chemoembolization.
    Wang ZX; Li J; Wang EX; Xia DD; Bai W; Wang QH; Yuan J; Li XM; Niu J; Yin ZX; Xia JL; Fan DM; Han GH
    World J Gastroenterol; 2020 Apr; 26(15):1805-1819. PubMed ID: 32351295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma.
    Cho JY; Paik YH; Park HC; Yu JI; Sohn W; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Liver Int; 2014 May; 34(5):795-801. PubMed ID: 24350564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of survival predictors in a prospective cohort of patients undergoing transarterial chemoembolization for hepatocellular carcinoma in a single Canadian centre.
    Eltawil KM; Berry R; Abdolell M; Molinari M
    HPB (Oxford); 2012 Mar; 14(3):162-70. PubMed ID: 22321034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palliative interventions for hepatocellular carcinoma patients: analysis of the National Cancer Database.
    Hammad AY; Robbins JR; Turaga KK; Christians KK; Gamblin TC; Johnston FM
    Ann Palliat Med; 2017 Jan; 6(1):26-35. PubMed ID: 28061532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MAAPE score in intermediate and advanced hepatocellular carcinoma treated with Yttrium-90 resin microsphere radioembolization.
    Wallace MC; Samuelson S; Khoo T; Ooi J; Tibballs J; Ferguson J; Preen DB; Knuiman M; Garas G; MacQuillan G; Adams LA; Jeffrey GP
    J Gastroenterol Hepatol; 2020 Nov; 35(11):1945-1952. PubMed ID: 32036614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant radiotherapy provided survival benefit compared to adjuvant radiotherapy for hepatocellular carcinoma.
    Lin H; Li X; Liu Y; Hu Y
    ANZ J Surg; 2018 Oct; 88(10):E718-E724. PubMed ID: 29399938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors of palliative radiotherapy response and survival in patients with spinal metastases from hepatocellular carcinoma.
    Choi C; Seong J
    Gut Liver; 2015 Jan; 9(1):94-102. PubMed ID: 25071067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and effectiveness of chemoembolization with drug-eluting beads for advanced-stage hepatocellular carcinoma.
    Kalva SP; Pectasides M; Liu R; Rachamreddy N; Surakanti S; Yeddula K; Ganguli S; Wicky S; Blaszkowsky LS; Zhu AX
    Cardiovasc Intervent Radiol; 2014 Apr; 37(2):381-7. PubMed ID: 23754191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transarterial chemoembolization in unresectable hepatocellular carcinoma--assessing the factors affecting the survival: An audit from a tertiary care center in northern India.
    Agarwal A; Yadav AK; Kumar A; Gupta S; Panwala HK; Redhu N; Hariprasad S; Ranjan P; Arora A; Gupta A
    Indian J Gastroenterol; 2015 Mar; 34(2):117-26. PubMed ID: 25937484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NIACE score for hepatocellular carcinoma patients treated by surgery or transarterial chemoembolization.
    Adhoute X; Pénaranda G; Raoul JL; Bollon E; Pol B; Letreut YP; Perrier H; Bayle O; Monnet O; Beaurain P; Muller C; Hardwigsen J; Lefolgoc G; Castellani P; Bronowicki JP; Bourlière M
    Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):706-715. PubMed ID: 28195873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation Therapy Is a Reasonable Option for Improving the Prognosis in Hepatocellular Carcinoma.
    Kondo Y; Kimura O; Kogure T; Ninomiya M; Umezawa R; Sugawara T; Matsushita H; Jingu K; Nakagome Y; Iwata T; Morosawa T; Fujisaka Y; Iwasaki T; Shimosegawa T
    Tohoku J Exp Med; 2015 Dec; 237(4):249-57. PubMed ID: 26560989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization.
    Liu MT; Li SH; Chu TC; Hsieh CY; Wang AY; Chang TH; Pi CP; Huang CC; Lin JP
    Jpn J Clin Oncol; 2004 Sep; 34(9):532-9. PubMed ID: 15466827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined transarterial chemoembolization and radiotherapy as a first-line treatment for hepatocellular carcinoma with macroscopic vascular invasion: Necessity to subclassify Barcelona Clinic Liver Cancer stage C.
    Kim YJ; Jung J; Joo JH; Kim SY; Kim JH; Lim YS; Lee HC; Kim JH; Yoon SM
    Radiother Oncol; 2019 Dec; 141():95-100. PubMed ID: 31506181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.